Oligodendroglioma

Oligodendroglioma is a type of brain tumor that arises from cells called oligodendrocytes, which help support nerve cells in the brain. This tumor primarily affects the central nervous system, especially the cerebral hemispheres. It can cause symptoms like headaches, seizures, and changes in thinking or movement depending on its location. The tumor grows slowly but can disrupt normal brain function by pressing on surrounding tissues. Diagnosis often involves imaging tests like MRI and sometimes a biopsy to confirm the tumor type. Treatment usually includes surgery, radiation, and sometimes chemotherapy to control growth. Understanding this tumor helps explain why neurological symptoms develop and guides medical care.

Oligodendroglioma is a primary intracranial glioma originating from oligodendrocytes, the myelin-producing glial cells of the central nervous system. It is characterized by a slow-growing, infiltrative neoplasm typically located in the cerebral white matter, especially the frontal lobes. The tumor is defined histologically by uniform cells with round nuclei and a clear cytoplasmic halo, often described as a 'fried egg' appearance. Molecularly, it is strongly associated with co-deletion of chromosomal arms 1p and 19q, which is a key diagnostic and prognostic marker. Clinically, it presents with seizures, focal neurological deficits, or signs of increased intracranial pressure. The presence of IDH1 or IDH2 mutations further refines diagnosis and prognosis. This tumor is significant due to its distinct biology, better prognosis compared to other gliomas, and responsiveness to combined modality therapy.